284 related articles for article (PubMed ID: 28330477)
1. Inhibition of human endogenous retrovirus-K by antiretroviral drugs.
Tyagi R; Li W; Parades D; Bianchet MA; Nath A
Retrovirology; 2017 Mar; 14(1):21. PubMed ID: 28330477
[TBL] [Abstract][Full Text] [Related]
2. Susceptibility of Human Endogenous Retrovirus Type K to Reverse Transcriptase Inhibitors.
Contreras-Galindo R; Dube D; Fujinaga K; Kaplan MH; Markovitz DM
J Virol; 2017 Dec; 91(23):. PubMed ID: 28931682
[TBL] [Abstract][Full Text] [Related]
3. Human endogenous retrovirus-K (HERV-K) reverse transcriptase (RT) structure and biochemistry reveals remarkable similarities to HIV-1 RT and opportunities for HERV-K-specific inhibition.
Baldwin ET; Götte M; Tchesnokov EP; Arnold E; Hagel M; Nichols C; Dossang P; Lamers M; Wan P; Steinbacher S; Romero DL
Proc Natl Acad Sci U S A; 2022 Jul; 119(27):e2200260119. PubMed ID: 35771941
[TBL] [Abstract][Full Text] [Related]
4. Quantitative analysis of human endogenous retrovirus-K transcripts in postmortem premotor cortex fails to confirm elevated expression of HERV-K RNA in amyotrophic lateral sclerosis.
Garson JA; Usher L; Al-Chalabi A; Huggett J; Day EF; McCormick AL
Acta Neuropathol Commun; 2019 Mar; 7(1):45. PubMed ID: 30885274
[TBL] [Abstract][Full Text] [Related]
5. Do Antiretroviral Drugs Protect From Multiple Sclerosis by Inhibiting Expression of MS-Associated Retrovirus?
Morandi E; Tanasescu R; Tarlinton RE; Constantin-Teodosiu D; Gran B
Front Immunol; 2018; 9():3092. PubMed ID: 30740110
[TBL] [Abstract][Full Text] [Related]
6. Human endogenous retroviruses in neurologic disease.
Christensen T
APMIS; 2016; 124(1-2):116-26. PubMed ID: 26818266
[TBL] [Abstract][Full Text] [Related]
7. Infectious Entry Pathway Mediated by the Human Endogenous Retrovirus K Envelope Protein.
Robinson LR; Whelan SP
J Virol; 2016 Jan; 90(7):3640-9. PubMed ID: 26792739
[TBL] [Abstract][Full Text] [Related]
8. A new endogenous retroviral sequence is expressed in skin of patients with psoriasis.
Molès JP; Tesniere A; Guilhou JJ
Br J Dermatol; 2005 Jul; 153(1):83-9. PubMed ID: 16029331
[TBL] [Abstract][Full Text] [Related]
9. Identification of an active reverse transcriptase enzyme encoded by a human endogenous HERV-K retrovirus.
Berkhout B; Jebbink M; Zsíros J
J Virol; 1999 Mar; 73(3):2365-75. PubMed ID: 9971820
[TBL] [Abstract][Full Text] [Related]
10. Human endogenous retroviruses and cancer prevention: evidence and prospects.
Cegolon L; Salata C; Weiderpass E; Vineis P; Palù G; Mastrangelo G
BMC Cancer; 2013 Jan; 13():4. PubMed ID: 23282240
[TBL] [Abstract][Full Text] [Related]
11. Expression of a human endogenous retrovirus, HERV-K, in the blood cells of leukemia patients.
Depil S; Roche C; Dussart P; Prin L
Leukemia; 2002 Feb; 16(2):254-9. PubMed ID: 11840292
[TBL] [Abstract][Full Text] [Related]
12. Modulation of human endogenous retrovirus (HERV) transcription during persistent and de novo HIV-1 infection.
Vincendeau M; Göttesdorfer I; Schreml JM; Wetie AG; Mayer J; Greenwood AD; Helfer M; Kramer S; Seifarth W; Hadian K; Brack-Werner R; Leib-Mösch C
Retrovirology; 2015 Mar; 12():27. PubMed ID: 25886562
[TBL] [Abstract][Full Text] [Related]
13. Biased nucleotide composition of the genome of HERV-K related endogenous retroviruses and its evolutionary implications.
Zsíros J; Jebbink MF; Lukashov VV; Voûte PA; Berkhout B
J Mol Evol; 1999 Jan; 48(1):102-11. PubMed ID: 9873082
[TBL] [Abstract][Full Text] [Related]
14. Reconstitution of an infectious human endogenous retrovirus.
Lee YN; Bieniasz PD
PLoS Pathog; 2007 Jan; 3(1):e10. PubMed ID: 17257061
[TBL] [Abstract][Full Text] [Related]
15. Contribution of Human Retroviruses to Disease Development-A Focus on the HIV- and HERV-Cancer Relationships and Treatment Strategies.
Liu CH; Grandi N; Palanivelu L; Tramontano E; Lin LT
Viruses; 2020 Aug; 12(8):. PubMed ID: 32759845
[TBL] [Abstract][Full Text] [Related]
16. Lamivudine, Doravirine, and Cabotegravir Downregulate the Expression of Human Endogenous Retroviruses (HERVs), Inhibit Cell Growth, and Reduce Invasive Capability in Melanoma Cell Lines.
Zanrè V; Bellinato F; Cardile A; Passarini C; Monticelli J; Di Bella S; Menegazzi M
Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338893
[TBL] [Abstract][Full Text] [Related]
17. A New Insight on Activation of Human Endogenous Retroviruses (HERVs) in Malignant Melanoma upon Exposure to CuSO4.
Karimi A; Sheervalilou R; Kahroba H
Biol Trace Elem Res; 2019 Sep; 191(1):70-74. PubMed ID: 30539386
[TBL] [Abstract][Full Text] [Related]
18. Monocyte activation and differentiation augment human endogenous retrovirus expression: implications for inflammatory brain diseases.
Johnston JB; Silva C; Holden J; Warren KG; Clark AW; Power C
Ann Neurol; 2001 Oct; 50(4):434-42. PubMed ID: 11601494
[TBL] [Abstract][Full Text] [Related]
19. Human endogenous retrovirus (HERV) expression is not induced by treatment with the histone deacetylase (HDAC) inhibitors in cellular models of HIV-1 latency.
Hurst T; Pace M; Katzourakis A; Phillips R; Klenerman P; Frater J; Magiorkinis G
Retrovirology; 2016 Feb; 13():10. PubMed ID: 26852322
[TBL] [Abstract][Full Text] [Related]
20. A new Real-Time-RT-PCR for quantitation of human endogenous retroviruses type K (HERV-K) RNA load in plasma samples: increased HERV-K RNA titers in HIV-1 patients with HAART non-suppressive regimens.
Contreras-Galindo R; González M; Almodovar-Camacho S; González-Ramírez S; Lorenzo E; Yamamura Y
J Virol Methods; 2006 Sep; 136(1-2):51-7. PubMed ID: 16678919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
